Can the acute-phase reactant proteins be used as cancer biomarkers?

International Journal of Biological Markers

Volumn 25, Issue 1, 2010, Pages 1-11

  Pang, Wei Wei ^a   Abdul Rahman, Puteri Shafinaz ^a   Wan Ibrahim, Wan Izlina ^a   Hashim, Onn Haji ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Acute phase reactant proteins; Biomarker; Cancer; Diagnosis; Serum

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA1 GLYCOPROTEIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; C REACTIVE PROTEIN; CERULOPLASMIN; CLUSTERIN; FETUIN A; HAPTOGLOBIN; HEMOPEXIN; KININOGEN; SERUM AMYLOID A;

ACUTE PHASE RESPONSE; BREAST CANCER; CELLULAR IMMUNITY; COLORECTAL CANCER; DISEASE MARKER; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; INNATE IMMUNITY; LIVER CANCER; LUNG CANCER; MULTIPLE MYELOMA; NEOPLASM; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEOMICS; REVIEW; STOMACH CANCER; UTERINE CERVIX CANCER;

EID: 77950984890     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500101     Document Type: Review

References (96)

1. Tillett WS, Francis T Jr. Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus J Exp Med 1930; 52: 561-571
2. Abernethy TJ, Avery OT. The occurrence during acute infections of a protein not normally present in the blood: I. Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with C-polysaccharide of Pneumococcus. J Exp Med 1941; 73: 173-182
3. Hiramatsu S, Kojima J, Okada TT, Inai S, Ohmori K. The serum protein profile in chronic hepatitis, cirrhosis and liver cancer. Acta Hepatogastroenterol (Stuttg) 1976; 23: 177-182
4. Thompson D, Bird HA. Acute phase response. In: Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld FC, eds. Oxford textbook of rheumatology. 3rd ed. Oxford: Oxford University Press 2004; 473-478
5. Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ, van Dijk E, Meloen RH. Monitoring health by values of acute phase proteins. Acta Histochem 2006; 108: 229-232 (Pubitemid 44026505)
6. Kushner I, Ganapathi M, Schultz D. The acute phase response is mediated by heterogeneous mechanisms. Ann N Y Acad Sci 1989; 557: 19-29; discussion: 30. (Pubitemid 19210812)
7. Mackiewicz A. Acute phase proteins and transformed cells. Int Rev Cytol 1997; 170: 225-300. (Pubitemid 27056587)
8. Kushner I, Mackiewicz A. Acute phase proteins as disease markers. Dis Markers 1987; 5: 1-11. (Pubitemid 17063156)
9. Jenne DE, Tschopp J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci U S A 1989; 86: 7123-7127 (Pubitemid 19240877)
10. Kirszbaum L, Sharpe JA, Murphy B, et al. Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems. EMBO J 1989; 8: 711-718
11. Trougakos IP, Gonos ES. Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 2002; 34: 1430-1448
12. Volanakis JE. Acute phase proteins in rheumatic disease. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology. 13 ed. Baltimore: Williams & Wilkins 1997; 505-514
13. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454 (Pubitemid 29084777)
14. Bank U, Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol 2001; 69: 197-206. (Pubitemid 32163431)
15. Cooper EH, Ward AM. Acute phase reactant proteins as aids to monitoring disease. Invest Cell Pathol 1979; 2: 293-301.
16. Samokyszyn VM, Miller DM, Reif DW, Aust SD. Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J Biol Chem 1989; 264: 21-26 (Pubitemid 19027569)
17. Gutteridge JM, Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 1988; 256: 861-865 (Pubitemid 19021714)
18. Kikuchi T, Abe T, Yaekashiwa M, et al. Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts. Am J Respir Cell Mol Biol 2000; 23: 364-370
19. Dabbagh K, Laurent GJ, Shock A, Leoni P, Papakrivopoulou J, Chambers RC. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol 2001; 186: 73-81.
20. Graziadei I, Gaggl S, Kaserbacher R, Braunsteiner H, Vogel W. The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake. Blood 1994; 83: 260-268
21. Banda MJ, Rice AG, Griffin GL, Senior RM. The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J Exp Med 1988; 167: 1608-1615
22. Joslin G, Fallon RJ, Bullock J, Adams SP, Perlmutter DH. The SEC receptor recognizes a pentapeptide neodomain of alpha 1-antitrypsin-protease complexes. J Biol Chem 1991; 266: 11282-11288 (Pubitemid 21906944)
23. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867
24. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002; 16: 217-26, 229; discussion 230-232
25. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545
26. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000; 248: 171-183 (Pubitemid 33702479)
27. Wahl LM, Kleinman HK. Tumor-associated macrophages as targets for cancer therapy. J Natl Cancer Inst 1998; 90: 1583-1584
28. Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ, Firestein GS. Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 2002; 99: 10025-10030 (Pubitemid 34831166)
29. Aoki Y, Yarchoan R, Braun J, Iwamoto A, Tosato G. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 2000; 96: 1599-1601 (Pubitemid 30658500)
30. Trentin L, Cerutti A, Zambello R, et al. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood 1996; 87: 3327-3335 (Pubitemid 26115363)
31. Bernacka K, Kuryliszyn-Moskal A, Sierakowski S. The levels of alpha 1-antitrypsin and alpha 1-antichymotrypsin in the sera of patients with gastrointestinal cancers during diagnosis. Cancer 1988; 62: 1188-1193
32. Stamatiadis AP, St Toumanidou M, Vyssoulis GP, Manouras AJ, Apostolidis NS. Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preoperative staging of colorectal cancer. A multivariate analysis. Cancer 1990; 65: 2055-2057
33. Solakidi S, Dessypris A, Stathopoulos GP, Androulakis G, Sekeris CE. Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and alpha1-antitrypsin in patients with gastrointestinal malignancies. Clin Biochem 2004; 37: 56-60. (Pubitemid 37522126)
34. Paternoster D, Cartei G, Campagnutta E, Maggino T, Valente S, Ongaro G. Acute reactive stage proteins in gynaecologic cancers. Eur J Gynaecol Oncol 1980; 1: 94-98 (Pubitemid 11139070)
35. Bhattacharyya J, Chaudhuri L. Alpha 1-antitrypsin: a possible tool for diagnosis of cervical cancer. Biochem Med Metab Biol 1990; 43: 243-245 (Pubitemid 20302861)
36. Nasulewicz A, Mazur A, Opolski A. Role of copper in tumour angiogenesis - clinical implications. J Trace Elem Med Biol 2004; 18: 1-8. (Pubitemid 39285958)
37. Itakura J, Ishiwata T, Friess H, et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 1997; 3: 1309-1316 (Pubitemid 27362391)
38. Zelvyte I, Wallmark A, Piitulainen E, Westin U, Janciauskiene S. Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res 2004; 24: 241-247 (Pubitemid 38279714)
39. El-Akawi ZJ, Al-Hindawi FK, Bashir NA. Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients. Neuro Endocrinol Lett 2008; 29: 482-484
40. Merlini G, Perfetti V, Gobbi PG, et al. Acute phase proteins and prognosis in multiple myeloma. Br J Haematol 1993; 83: 595-601. (Pubitemid 23117437)
41. Koebl H, Tatra G, Bieglmayer C. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring. Neoplasma 1988; 35: 215-220
42. Buamah PK, Skillen AW. Concentrations of protease and anti-protease in serum of patients with pancreatic cancer. Clin Chem 1985; 31: 876-877 (Pubitemid 16140544)
43. Tountas Y, Sparos L, Theodoropoulos C, Trichopoulos D. Alpha 1-antitrypsin and cancer of the pancreas. Digestion 1985; 31: 37-40.
44. Kuvibidila S, Rayford W. Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancer. J Lab Clin Med 2006; 147: 174-181
45. Kalabay L, Jakab L, Prohaszka Z, et al. Human fetuin/ alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer. Eur J Gastroenterol Hepatol 2002; 14: 389-394 (Pubitemid 34439037)
46. Stejskal D, Fiala RR. Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer. Neoplasma 2006; 53: 343-346 (Pubitemid 44105942)
47. Kirchheimer JC, Kolbl H, Tatra G, Binder BR. Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactants in patients with uterine malignancies. Eur J Clin Invest 1990; 20: 79-84. (Pubitemid 20056277)
48. Arumanayagam M, Wong FW, Rogers M, Swaminathan R. Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical carcinoma. Gynecol Obstet Invest 1993; 35: 175-178 (Pubitemid 23115489)
49. Gundogdu M, Kaya H, Gulcin I, et al. Oxidase activity of ceruloplasmin and some acute phase reactant and trace element concentrations in serum of patients with chronic lymphocytic leukemia. Scott Med J 2007; 52: 24-27 (Pubitemid 46403621)
50. Tsavaris N, Kosmas C, Kopterides P, et al. Retinol-binding protein, acute phase reactants and Helicobacter pylori infection in patients with gastric adenocarcinoma. World J Gastroenterol 2005; 11: 7174-7178 (Pubitemid 43154015)
51. Boz A, Evliyaoglu O, Yildirim M, Erkan N, Karaca B. The value of serum zinc, copper, ceruloplasmin levels in patients with gastrointestinal tract cancers. Turk J Gastroenterol 2005; 16: 81-84 (Pubitemid 41020238)
52. Agroyannis B, Dalamangas A, Dardouphas K, et al. Serum transferrin and ceruloplasmin in patients with cancer of the gastrointestinal and other systems. Anticancer Res 1994; 14: 2201-2203
53. Pejovic M, Djordjevic V, Ignjatovic I, Stamenic T, Stefanovic V. Serum levels of some acute phase proteins in kidney and urinary tract urothelial cancers. Int Urol Nephrol 1997; 29: 427-432 (Pubitemid 27496167)
54. Esme H, Cemek M, Sezer M, et al. High levels of oxidative stress in patients with advanced lung cancer. Respirology 2008; 13: 112-116
55. Ros-Bullon MR, Sanchez-Pedreno P, Martinez-Liarte JH. Serum ceruloplasmin in melanoma patients. Anticancer Res 2001; 21: 629-632
56. Senra Varela A, Lopez Saez JJ, Quintela Senra D. Serum ceruloplasmin as a diagnostic marker of cancer. Cancer Lett 1997; 121: 139-145 (Pubitemid 28008912)
57. Avall Lundqvist E, Blad E, Xiao L, Sjovall K, Eneroth P. Pretreatment serum levels of C-reactive protein, alpha 1-antitrypsin, haptoglobin, alpha 1-acid glycoprotein and tissue polypeptide antigen in cervical carcinoma. Eur J Gynaecol Oncol 1991; 12: 375-383
58. Zhao J, Patwa TH, Qiu W, et al. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. J Proteome Res 2007; 6: 1864-1874 (Pubitemid 46814510)
59. Roeise O, Sivertsen S, Ruud TE, Bouma BN, Stadaas JO, Aasen AO. Studies on components of the contact phase system in patients with advanced gastrointestinal cancer. Cancer 1990; 65: 1355-1359 (Pubitemid 20097162)
60. Srinivas PR, Wagner AS, Reddy LV, et al. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 1993; 7: 1445-1455 (Pubitemid 2021156)
61. Kalabay L, Chavin K, Lebreton JP, Robinson KA, Buse MG, Arnaud P. Human recombinant alpha 2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase. Horm Metab Res 1998; 30: 1-6. (Pubitemid 28064629)
62. Raghothama C, Akhilesh P. Quantitative proteomics for identification of cancer biomarkers. Proteomics - Clinical Applications 2007; 1: 1080-1089
63. Simpson RJ, Bernhard OK, Greening DW, Moritz RL. Proteomics-driven cancer biomarker discovery: looking to the future. Curr Opin Chem Biol 2008; 12: 72-77
64. Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 2007; 6: 25.
65. Adkins JN, Varnum SM, Auberry KJ, et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 2002; 1: 947-955
66. Wang YY, Cheng P, Chan DW. A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis. Proteomics 2003; 3: 243-248 (Pubitemid 36343679)
67. Pieper R, Gatlin CL, Makusky AJ, et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003; 3: 1345-1364 (Pubitemid 36929557)
68. Ahmed N, Barker G, Oliva KT, et al. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer 2004; 91: 129-140 (Pubitemid 39013057)
69. Granger J, Siddiqui J, Copeland S, Remick D. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 2005; 5: 4713-4718 (Pubitemid 43016893)
70. Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 2005; 4: 409-418
71. Hamrita B, Chahed K, Trimeche M, et al. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. Clin Chim Acta 2009; 404: 111-118
72. Ward DG, Suggett N, Cheng Y, et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 2006; 94: 1898-1905 (Pubitemid 43882582)
73. Patz EF Jr, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE 2nd. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007; 25: 5578-5583
74. Sun ZL, Zhu Y, Wang FQ, et al. Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers. Biochim Biophys Acta 2007; 1774: 764-771 (Pubitemid 46856286)
75. Koomen JM, Shih LN, Coombes KR, et al. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 2005; 11: 1110-1118
76. Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 2005; 4: 1742-1751 (Pubitemid 41464802)
77. Kwak JY, Ma TZ, Yoo MJ, et al. The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia. Exp Hematol 2004; 32: 836-842
78. Dowling P, O'Driscoll L, Meleady P, et al. 2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. Electrophoresis 2007; 28: 4302-4310 (Pubitemid 350259032)
79. Bloomston M, Zhou JX, Rosemurgy AS, Frankel W, Muro- Cacho CA, Yeatman TJ. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res 2006; 66: 2592-2599
80. Rodriguez-Pineiro AM, de la Cadena MP, Lopez-Saco A, Rodriguez-Berrocal FJ. Differential expression of serum clusterin isoforms in colorectal cancer. Mol Cell Proteomics 2006; 5: 1647-1657 (Pubitemid 44480392)
81. Zhang LY, Ying WT, Mao YS, et al. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches. World J Gastroenterol 2003; 9: 650-654
82. Hanas JS, Hocker JR, Cheung JY, et al. Biomarker identification in human pancreatic cancer sera. Pancreas 2008; 36: 61-69
83. Huang HL, Stasyk T, Morandell S, et al. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis 2006; 27: 1641-1650
84. Chen CB, Su YC, Huang TT, et al. Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer. Clin Chim Acta 2008; 398: 48-52.
85. Ang IL, Poon TC, Lai PB, et al. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J Proteome Res 2006; 5: 2691-2700
86. Maciel CM, Junqueira M, Paschoal ME, et al. Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J Exp Ther Oncol 2005; 5: 31-38 (Pubitemid 41076988)
87. Ye B, Cramer DW, Skates SJ, et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res 2003; 9: 2904-2911 (Pubitemid 36993248)
88. Heo SH, Lee SJ, Ryoo HM, Park JY, Cho JY. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 2007; 7: 4292-4302
89. Deng R, Lu Z, Chen Y, Zhou L, Lu X. Plasma proteomic analysis of pancreatic cancer by 2-dimensional gel electrophoresis. Pancreas 2007; 34: 310-317 (Pubitemid 46588256)
90. Kakisaka T, Kondo T, Okano T, et al. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 852: 257-267 (Pubitemid 46830120)
91. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem 2007; 53: 673-678
92. Doustjalali SR, Yusof R, Yip CH, Looi LM, Pillay B, Hashim OH. Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors. Electrophoresis 2004; 25: 2392-2401 (Pubitemid 39136360)
93. Doustjalali SR, Yusof R, Govindasamy GK, Bustam AZ, Pillay B, Hashim OH. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J Med Invest 2006; 53: 20-28
94. Abdul-Rahman PS, Lim BK, Hashim OH. Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods. Electrophoresis 2007; 28: 1989-1996
95. Chen Y, Lim BK, Peh SC, Abdul-Rahman PS, Hashim OH. Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma. Proteome Sci 2008; 6: 20.
96. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42: 1589-1600 (Pubitemid 26354735)